Dr Brkljača obtained his PhD in Chemistry at RMIT University and has extensive experience in Nuclear Magnetic Resonance. He is the facility manager and imaging support scientist at Alfred Research Alliance-Monash Biomedical Imaging (ARA-MBI), and assists researchers using the 9.4T MRI system including training, troubleshooting, data analysis, and imaging procedures.
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
The Governor-General, Her Excellency the Honourable Sam Mostyn AC has announced the award of Australian Cancer Research Foundation’s (ACRF) 2024 grants at Government House in Canberra. The announcem
25 November 2024
Idrish Ali, Bianca Jupp, Matthew R. Hudson, Brendan Major, Juliana Silva, Glenn R. Yamakawa, Pablo M. Casillas-Espinosa, Emma Braine, Peravina Thergarajan, Mohammad B. Haskali, Lucy Vivash, Robert Brkljaca, Sandy R. Shultz, Patrick Kwan, Kazuyuki Fukushima, Pallavi Sachdev, Jocelyn Y. Cheng, Richelle Mychasiuk, Nigel C. Jones, David K. Wright, Terence J. OBrien
Read Publication
Lucy F. Costello, Hazel L. Richards, Alistair R. Evans, Justin W. Adams
Read Publication
Jinlong He, Gang Liu, Pengfei Li, Xiaonan Su, Wenhua Jiang, Dongze Zhang, Shenjun Zhong
Read Publication
Jaideep Singh, Kristy L Jackson, Haoyun Fang, Audrey Gumanti, Bethany Claridge, Feng Shii Tang, Helen Kiriazis, Ekaterina Salimova, Alex M Parker, Cameron Nowell, Owen L Woodman, David W Greening, Rebecca H Ritchie, Geoffrey A Head, Cheng Xue Qin
Read Publication